Tag

Genmab

Jan van de Winkel

Approval for Genmab’s DARZALEX in Japan

October 2, 2017

The Ministry of Health, Labor …

Jan Van de Winkel

Genmab and Seattle Genetics in co-development agreement

August 30, 2017

Genmab and Seattle Genetics announces …

laboratory-technician-protein-separation_genmab

Genmab announces European marketing authorization for DARZALEX

May 3, 2017

Genmab announces that the European …

jan-van-de-winkel-ceo-b-w-portrait

Genmab announces new phase III study

May 2, 2017

Genmab announces that Janssen Research …

judith_klimovsky

Genmab appoints new Chief Development Officer

February 9, 2017

Genmab has appointed Judith Klimovsky, MD, …

Genmab receives USD 25 million in sales milestone

January 9, 2017

Genmab A/S has achieved the …

Pharma Business

809 Views

FDA approval for Genmab

November 22, 2016

The U.S. Food and Drug …

Clinical Trials

734 Views

Genmab announces Phase III Study

November 3, 2016

Genmab announces that daratumumab (DARZALEX) …

jan_van_de_winkel

Genmab announces European Regulatory Submission

August 24, 2016

Genmab announced yesterday that Janssen …

Drug Development Pharma

703 Views

Genmab submits FDA application for Daratumumab

August 18, 2016

Genmab has announced that its licensing …

Agreement

774 Views

Genmab in new agreement

August 15, 2016

Genmab has entered an agreement …

Clinical Trials

687 Views

Genmab anounce Phase III studies

June 2, 2016

Genmab A/S announces that its …

Pharma Business

700 Views

Genmab’s Darzalex receives market authorization

May 25, 2016

Genmab A/S announces that the …

Drug Development Pharma

846 Views

Genmab’s Darzalex approved in Europe

May 24, 2016

Genmab has announced that the European …

Pharma Business

729 Views

Genmab’s quarterly report

May 11, 2016

Genmab has announced their financial …

Drug Development Pharma

760 Views

Ofatumumab treatment accepted for priority review by FDA

May 10, 2016

Genmab has announced that the …

1
2